Your browser doesn't support javascript.
loading
TGFß signalling is required to maintain pluripotency of human naïve pluripotent stem cells.
Osnato, Anna; Brown, Stephanie; Krueger, Christel; Andrews, Simon; Collier, Amanda J; Nakanoh, Shota; Quiroga Londoño, Mariana; Wesley, Brandon T; Muraro, Daniele; Brumm, A Sophie; Niakan, Kathy K; Vallier, Ludovic; Ortmann, Daniel; Rugg-Gunn, Peter J.
Afiliação
  • Osnato A; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.
  • Brown S; Department of Surgery, University of Cambridge, Cambridge, United Kingdom.
  • Krueger C; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.
  • Andrews S; Department of Surgery, University of Cambridge, Cambridge, United Kingdom.
  • Collier AJ; Bioinformatics Group, The Babraham Institute, Cambridge, United Kingdom.
  • Nakanoh S; Bioinformatics Group, The Babraham Institute, Cambridge, United Kingdom.
  • Quiroga Londoño M; Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom.
  • Wesley BT; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.
  • Muraro D; Department of Surgery, University of Cambridge, Cambridge, United Kingdom.
  • Brumm AS; Division of Embryology, National Institute for Basic Biology, Okazaki, Japan.
  • Niakan KK; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.
  • Vallier L; Department of Surgery, University of Cambridge, Cambridge, United Kingdom.
  • Ortmann D; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.
  • Rugg-Gunn PJ; Department of Surgery, University of Cambridge, Cambridge, United Kingdom.
Elife ; 102021 08 31.
Article em En | MEDLINE | ID: mdl-34463252
The signalling pathways that maintain primed human pluripotent stem cells (hPSCs) have been well characterised, revealing a critical role for TGFß/Activin/Nodal signalling. In contrast, the signalling requirements of naive human pluripotency have not been fully established. Here, we demonstrate that TGFß signalling is required to maintain naive hPSCs. The downstream effector proteins - SMAD2/3 - bind common sites in naive and primed hPSCs, including shared pluripotency genes. In naive hPSCs, SMAD2/3 additionally bind to active regulatory regions near to naive pluripotency genes. Inhibiting TGFß signalling in naive hPSCs causes the downregulation of SMAD2/3-target genes and pluripotency exit. Single-cell analyses reveal that naive and primed hPSCs follow different transcriptional trajectories after inhibition of TGFß signalling. Primed hPSCs differentiate into neuroectoderm cells, whereas naive hPSCs transition into trophectoderm. These results establish that there is a continuum for TGFß pathway function in human pluripotency spanning a developmental window from naive to primed states.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Diferenciação Celular / Fator de Crescimento Transformador beta / Células-Tronco Pluripotentes / Proteína Smad2 / Proteína Smad3 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Diferenciação Celular / Fator de Crescimento Transformador beta / Células-Tronco Pluripotentes / Proteína Smad2 / Proteína Smad3 Idioma: En Ano de publicação: 2021 Tipo de documento: Article